The Beaujon Hospital is located in Clichy, Paris, France and is operated by APHDP. It was named after Nicolas Beaujon, an eighteenth-century French banker. It opened in 1935 and was designed by Jean Walter.

There are 464 beds in Hôpital Beaujon.

During the past decade, Hôpital Beaujon conducted 178 clinical trials. In the 10-year time frame, 178 clinical trials started and 48 clinical trials were completed, i.e. on average, 27% percent of trials that started reached the finish line to date. In the past 5 years, 79 clinical trials started and 31 clinical trials were completed. i.e. 39.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Beaujon" #1 sponsor was "Assistance Publique - Hôpitaux de Paris" with 40 trials, followed by "Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives" with 22 trials sponsored, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 18 trials sponsored, "Gilead Sciences" with 15 trials sponsored and "Janssen Research & Development, LLC" with 15 trials sponsored. Other sponsors include 206 different institutions and companies that sponsored additional 121 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Beaujon" #1 collaborator was "Ministry of Health, France" with 8 trials as a collaborator, "Gilead Sciences" with 5 trials as a collaborator, "National Cancer Institute, France" with 5 trials as a collaborator, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 4 trials as a collaborator and "AbbVie" with 3 trials as a collaborator. Other collaborators include 110 different institutions and companies that were collaborators in the rest 104 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Beaujon" are "Ulcerative Colitis" (25 trials), "Crohn's Disease" (22 trials), "Crohn Disease" (12 trials), "Hepatocellular Carcinoma" (12 trials) and "Pancreatic Cancer" (10 trials). Many other conditions were trialed in "Hôpital Beaujon" in a lesser frequency.

Most popular intervention types in "Hôpital Beaujon" are "Drug" (193 trials), "Other" (46 trials), "Procedure" (36 trials), "Device" (31 trials) and "Biological" (17 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (46 trials), "Gemcitabine" (8 trials), "JNJ-73763989" (7 trials), "gemcitabine hydrochloride" (7 trials) and "radiation therapy" (6 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Beaujon" are 312 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are 86 active trials in "Hôpital Beaujon". 3 are not yet recruiting, 46 are recruiting, 34 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 174 completed trials in Hôpital Beaujon, 2 suspended trials, and 28 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Beaujon, 9 "Phase 1" clinical trials were conducted, 78 "Phase 2" clinical trials and 106 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 19 trials, and there were also 54 trials that are defined as “Not Applicable".